"Dronabinol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.
| Descriptor ID |
D013759
|
| MeSH Number(s) |
D02.455.849.090.810
|
| Concept/Terms |
Dronabinol- Dronabinol
- delta(9)-THC
- 9-ene-Tetrahydrocannabinol
- 9 ene Tetrahydrocannabinol
- THC
- delta(1)-Tetrahydrocannabinol
- delta(1)-THC
- delta(9)-Tetrahydrocannabinol
- Tetrahydrocannabinol
|
Below are MeSH descriptors whose meaning is more general than "Dronabinol".
Below are MeSH descriptors whose meaning is more specific than "Dronabinol".
This graph shows the total number of publications written about "Dronabinol" by people in this website by year, and whether "Dronabinol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 2 | 5 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 3 | 4 |
| 2019 | 4 | 2 | 6 |
| 2020 | 3 | 2 | 5 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dronabinol" by people in Profiles.
-
Changes in striatal dopamine release, sleep, and behavior during spontaneous ?-9-tetrahydrocannabinol abstinence in male and female mice. Neuropsychopharmacology. 2022 07; 47(8):1537-1549.
-
Cannabinoid use is enhanced by stress and changes conditioned stress responses. Neuropsychopharmacology. 2022 04; 47(5):1037-1045.
-
Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli. Behav Brain Res. 2021 10 11; 415:113517.
-
Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis. J Crohns Colitis. 2021 Jun 22; 15(6):1032-1048.
-
Protective effects of ?9 -tetrahydrocannabinol against enterotoxin-induced acute respiratory distress syndrome are mediated by modulation of microbiota. Br J Pharmacol. 2020 11; 177(22):5078-5095.
-
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis. J Cyst Fibros. 2021 01; 20(1):78-85.
-
?9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Int J Mol Sci. 2020 Aug 28; 21(17).
-
Long Noncoding RNA AW112010 Promotes the Differentiation of Inflammatory T Cells by Suppressing IL-10 Expression through Histone Demethylation. J Immunol. 2020 08 15; 205(4):987-993.
-
ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites. J Med Toxicol. 2020 04; 16(2):240-242.
-
The effects of chronic ?-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study. Appl Physiol Nutr Metab. 2020 Apr; 45(4):450-452.